AB SCIEX Expands Commercial Operations in Korea
Company Goes Direct with Highly Experienced Sales Force to Support Korean Scientific Community
SEOUL, South Korea – AB SCIEX, a global leader in life science analytical technologies, today announced that the company has expanded its commercial operations in Korea. The company created a new direct sales organization under AB SCIEX Korea to help customers located in Korea advance drug discovery, biomedical science, food and environmental safety testing, forensics and clinical research through the use of mass spectrometry technologies. This expansion was made possible by an agreement with Life Science Korea (LSK) to transfer existing sales, service and marketing personnel to AB SCIEX, effective immediately.
LSK was formerly the official dealer for AB SCIEX in Korea, providing scientists in the Korean scientific community with access to acquire best-in-class mass spectrometry technologies from AB SCIEX. The shift from indirect sales through LSK to direct sales with AB SCIEX associates within the country is intended to enhance customer support and collaborations by providing one point of contact for instrument pre-sales demonstrations, purchase, installation, application support and service. The new personnel joining AB SCIEX from LSK will be based at AB SCIEX Korea’s new office in Seoul.
AB SCIEX has a more than 20-year history of innovation and is a market leader in mass spectrometry with more than 12,000 systems installed in laboratories worldwide, including a strong presence across Asia-Pacific. Mass spectrometry is a workhorse analytical technique for a wide variety of scientific applications, including basic research, pharmaceutical development, food contamination testing and vitamin D analysis, among other emerging applications. AB SCIEX is focused on providing innovative instrument systems, such as the new AB SCIEX TripleTOF™ 5600 System and AB SCIEX QTRAP® 5500 Systems, along with intuitive software and comprehensive workflows that simplify and facilitate the use of these technologies.
Vince Gao, Sr. Director, APAC Sales, Support & Customer Service, AB SCIEX
“AB SCIEX has a commitment to invest for long-term growth in emerging markets, such as Korea. The expansion of our commercial team elevates our presence in Korea and positions us to better serve our Korean customers who are among the leaders helping to drive science forward in this region. With the integration of the sales, service and support functions into AB SCIEX Korea, we will be able to make faster decisions and simplify the purchase process, so our customers can focus on achieving their goals.”
About AB SCIEX
AB SCIEX is a global leader in the development of life science analytical technologies that help answer complex scientific challenges. The company provides scientific instrumentation, software and services used to discover new drugs, advance medical science and protect the food supply and the environment. AB SCIEX technology solutions combine the highest performance with the highest reliability to enable our customers to fuel scientific discovery, deliver results with confidence and improve the quality of life. The company has a more than 20-year history of innovation and market leadership as the former Applied Biosystems/MDS Analytical Technologies joint venture. For more information about AB SCIEX, go to www.absciex.com. Follow AB SCIEX on Twitter @ABSCIEX and on Facebook.
For Research Use Only. Not for use in diagnostic procedures. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEXTM is being used under license.